Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of YYC506-T and YYC506-A Interaction
NCT04874142Phase 1Completed
- Sponsor
- Yooyoung Pharmaceutical
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of atorvastatin and fenofibrate in dyslipidemia (2 arms), sponsored by Yooyoung Pharmaceutical. Primary endpoints: Maximum Plasma Concentration at 48 hours and Area Under the Curve at 48 hours. Started Nov 2019; status: completed.
02
Drugs
atorvastatinfenofibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT04874142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04874142.